Literature DB >> 6809974

Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease.

C L Morin, M Roulet, C C Roy, A Weber, N Lapointe.   

Abstract

Ten pediatric patients, aged 8.5-19 years, with active symptomatic Crohn's disease, received a three-week period of continuous elemental enteral alimentation with no other form of treatment. All patients in this study were selected according to the following criteria, which were applied consecutively: (1) newly diagnosed patients with no previous treatment for Crohn's disease, (2) disease activity index over 200, and (3) no complication requiring surgery. All patients experienced a clinical remission and improved their immunologic and nutritional status during the elemental enteral alimentation. The mean disease activity index for the whole group was 307.0 +/- 23.6 (range: 203 to 413) before and 69.2 +/- 11.4 (range: 15 to 114) after the feeding period. Significant increases in body weight, triceps skinfold, mid-arm circumference, serum transferrin and mean percentage of T lymphocytes were also observed. Following cessation of enteral alimentation, a small declining dose of prednisone was used during a one-year follow-up period. Eight of the ten patients were still in clinical remission three months after the feeding period and their nutritional status had continued to improve during that period of time.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809974     DOI: 10.1177/0148607182006003194

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  8 in total

1.  Significance of serum sialic acid in patients with Crohn's disease.

Authors:  R Baba; K Yashiro; K Nagasako; H Obata
Journal:  Gastroenterol Jpn       Date:  1992-10

Review 2.  Nutritional status and nutritional therapy in inflammatory bowel diseases.

Authors:  Corina Hartman; Rami Eliakim; Raanan Shamir
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

3.  Effect of dietary fat and residues on fecal loss of sterols and on their microbial degradation in cystic fibrosis.

Authors:  C Leroy; G Lepage; C L Morin; J M Bertrand; O Dufour-Larue; C C Roy
Journal:  Dig Dis Sci       Date:  1986-09       Impact factor: 3.199

Review 4.  Current therapy of inflammatory bowel disease in children.

Authors:  Paul A Rufo; Athos Bousvaros
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

5.  Is tube feeding with elemental diets a primary therapy of Crohn's disease?

Authors:  H Lochs; M Egger-Schödl; R Schuh; S Meryn; G Westphal; R Pötzi
Journal:  Klin Wochenschr       Date:  1984-09-03

6.  Controlled trial of oligopeptide versus amino acid diet in treatment of active Crohn's disease.

Authors:  J C Mansfield; M H Giaffer; C D Holdsworth
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

7.  Remission induced by an elemental diet in small bowel Crohn's disease.

Authors:  I R Sanderson; S Udeen; P S Davies; M O Savage; J A Walker-Smith
Journal:  Arch Dis Child       Date:  1987-02       Impact factor: 3.791

Review 8.  Enteral nutrition in Crohn's disease: an underused therapy.

Authors:  S Kansal; J Wagner; C D Kirkwood; A G Catto-Smith
Journal:  Gastroenterol Res Pract       Date:  2013-12-05       Impact factor: 2.260

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.